Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Exp Eye Res. 2021 Jun 12;209:108662. doi: 10.1016/j.exer.2021.108662

Table 1. Genes and Loci Implicated in Mendelian Cataracts.

1: Lens Crystallins, 2: Transcription and Developmental Factors, 3: Gap Junction Proteins (Connexins), 4: Membranes, Channels and Transporters, 5: Beaded Filament, Intermediate Filaments and Cytoskeleton, 6: Chaperones and Protein Degradation, 7: Mitochondria and Metabolic 8: Other, 9: Unknown locus. Only genes implicated in isolated cataracts are listed. A more complete compilation including individual mutations can be found in Cat-Map: https://cat-map.wustl.edu/.

Locus Gene INH MIM no. Gene/Locus MIM no. Associated extralenticular phenotypes Class Reference
1 1pter-p36.13 RP1–140A9.1 AD 115665 NA Volkman 8 (Eiberg et al., 1995)
2 1p36.32 PANK4 AD NA 606162 7 (Sun et al., 2019)
3 1p36.13 EPHA2 AD/AR 116600 176946 Susceptibility to age-related cortical cataract, 2 (Shiels et al., 2008)
4 1p32 FOXE3 AR 612968 601094 With or without microcornea, microphthalmia, aphakia, coloboma 2 (Semina et al., 2001)
5 1q21.1 GJA8 AD/AR 116200 600897 With or without microcornea 3 (Shiels et al., 1998)
6 1q12–24 MYOC Sporadic 601652 5 (Li et al., 2016)
7 1q25–31 ? AD 9 (Wang et al., 2007b)
8 1q41 IARS2 AR 616007 612801 skeletal dysplasia, GH deficiency, sensory neuropathy in some 7 (Li et al., 2018)
9 2pter-p24 CTRCT29 AD 115800 NA 9 (Gao et al., 2005)
10 2p12 CTRCT27 AD 607304 NA 9 (Khaliq et al., 2002)
11 2q33.3 CRYGD AD 115700 123690 With or without microcornea 1 (Heon et al., 1999)
12 2q33.3 CRYGC AD 604307 123680 With or without microcornea 1 (Heon et al., 1999)
13 2q33.3 CRYGB AD 615188 123670 1 (AlFadhli et al., 2012)
14 2q33.3 CRYGA AD 123660 1 (Li et al., 2016)
15 2q34 CRYBA2 AD 115900 600836 1 (Reis et al., 2013)
16 3p21.31 FYCO1 AR 610019 607182 6 (Chen et al., 2011)
17 3q22.1 BFSP2 AD 611597 603212 Myopia 5 (Jakobs et al., 2000)
18 3q27.3 CRYGS AD 116100 123730 1 (Zhai et al., 2017)
19 3q28 P3H2 AR 614292 610341 Myopia, ectopis lentis, vitreoretinal degeneration 5 V7(Khan et al., 2015b)
20 4p16.1 WFS1 AD 116400 606201 Wolfram syndrome (DIDMOAD) 4 (Berry et al., 2013)
21 5q22 WDR36 Sporadic 609887 609669 POAG 2 (Li et al., 2016)
22 6p24 GCNT2 AR 110800 600429 Adult i blood group phenotype 4 (Yu et al., 2001)
23 6p12-q12 CTRCT28 ? 609026 NA Age-related cortical cataract, susceptibility to 9 (Iyengar et al., 2004)
24 6p21.31 LEMD2 AR 212500 616312 4 (Boone et al., 2016)
25 7q21-q31 ? AR 9 (Kaul et al., 2010b)
26 7q21/2 CYP51A1 AR 601637 hepatic failure, developmental delay 4 (Aldahmesh et al., 2012)
27 7q34 AGK AR 614691 610345 Senger’s syndrome 4 (Aldahmesh et al., 2012)
28 8q13.3 EYA1 AD 602588 601653 Branchio-oto-renal syndrome, ASD 2 (Azuma et al., 2000)
29 9p22.1 RRAGA AD 612194 6 (Chen et al., 2016)
30 9q13-q22 CTPL1 AR 605749 NA 9 (Heon et al., 2001)
31 9q21.12-q21.13 TRPM3 608961 POAG 4 (Bennett et al., 2014)
32 9q22.33 TDRD7 AR 613887 611258 2 (Lachke et al., 2011)
33 10p15.1 AKR1E2 AR 617451 7 (Aldahmesh et al., 2012)
34 10p13 VIM AD 116300 193060 5 (Muller et al., 2009)
35 10p23.31 RNLS AR 609360 7 (Aldahmesh et al., 2012)
36 10q23.13 SLC16A12 AD 612018 611910 4 (Kloeckener-Gruissem et al., 2008)
37 10q24.2 DNMBP AR 618415 611282 5 (Ansar et al., 2018)
38 10q24.32 PITX3 AD 610623 602669 Anterior segment mesenchymal dysgenesis, microphthalmia, neurodevelopmental abnormalities 2 (Semina et al., 1998)
39 11q22.3 CRYAB AD/AR 613763 123590 Myopathy, multiple types 1 (Vicart et al., 1998)
40 12q13.3 MIP AD 615274 154050 4 (Berry et al., 2000)
41 12q24.2-q24.3 CTRCT37 AD 614422 NA 9 (Berry et al., 2011)
42 13q12.1 GJA3 AD 601885 121015 3 (Mackay et al., 1999)
43 13q34 COL4A1 AD 120130 5 (Xia et al., 2014)
44 14q11.2 SLC7A8 AR 604235 4 (Knopfel et al., 2019)
45 14q22-q23 CTRCT32 AD 11565000 NA 9 (Pras et al., 2006)
46 15q21-q22 CTRCT25 AD 605728 NA 9 (Vanita et al., 2000)
47 16q21 HSF4 AD/AR 116800 602438 2 (Bu et al., 2002)
48 16q22-q23 MAF AD 610202 177075 With or without microcornea 2 (Jamieson et al., 2002)
49 17p13.3 TSR1 611214 8 (Yu et al., 2020)
50 17p13 CTAA2 AD 601202 NA 9 (Berry et al., 1996)
51 17q11.2 CRYBA1 AD 600881 123610 1 (Kannabiran et al., 1998)
52 17q12 UNC45B AD 616279 611220 6 (Hansen et al., 2014)
53 17q24 CCA1 AD 115660 NA 9 (Armitage et al., 1995)
54 19p13.2 LONP1 AR 605490 Also CODAS syndrome 7 (Khan et al., 2015a)
55 19q13 CTRCT35 AR 609376 NA 9 (Riazuddin et al., 2005b)
56 19q13 ADPCZNC AD 9 (Li et al., 2006b)
57 19q13.13 WDR87 AR ? (Khan et al., 2015a)
58 19q13.1–13.2 SIPA1L3 AR 616851 616655 2 (Greenlees et al., 2015)
59 19q13.41 LIM2 AR 615277 154045 4 (Pras et al., 2002)
60 19q13-qter ? AD 9 (Zhao et al., 2011)
61 20p13 ADPCZNC AD 9 (Li et al., 2006a)
62 20p12.1 BFSP1 AR 611391 603307 5 (Ramachandran et al., 2007)
63 20q11.21 CHMP4B AD 605387 610897 6 (Shiels et al., 2007)
64 20q11 NCOA6 AD 605299 2 (Kandaswamy et al., 2020)
65 21q22.3 CRYAA AD/AR 604219 123580 With or without microcornea, susceptibility to age-related nuclear cataract 1 (Litt et al., 1998)
66 21q22.3 LSS AR 616509 600909 4 (Zhao et al., 2015)
67 22q11.23 CRYBB3 AD/AR 609741 123630 1 (Riazuddin et al., 2005a)
68 22q11.23 CRYBB2 AD 601547 123620 With or without microcornea 1 (Litt et al., 1997)
69 22q12.1 CRYBB1 AD/AR 611544 6009291 1 (Mackay et al., 2002)
70 22q12.1 CRYBA4 AD 610425 123631 1 (Billingsley et al., 2006)
71 Xp22.13 NHS X-linked 302200 300457 Nance-Horan (cataract dental) syndrome 2 (Burdon et al., 2003)
HHS Vulnerability Disclosure